Liangji Li

880 total citations
9 papers, 366 citations indexed

About

Liangji Li is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Liangji Li has authored 9 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Liangji Li's work include Cancer Cells and Metastasis (3 papers), RNA modifications and cancer (2 papers) and Muscle Physiology and Disorders (2 papers). Liangji Li is often cited by papers focused on Cancer Cells and Metastasis (3 papers), RNA modifications and cancer (2 papers) and Muscle Physiology and Disorders (2 papers). Liangji Li collaborates with scholars based in United States, China and Germany. Liangji Li's co-authors include Chen‐Ming Fan, Michelle Rozo, Yuan Li, Shanshan Guo, Li‐Ting Liu, Hai‐Qiang Mai, Shibing Li, Lin‐Quan Tang, Tianliang Xia and Chaochao Du and has published in prestigious journals such as Cell, Nature Medicine and Development.

In The Last Decade

Liangji Li

6 papers receiving 366 citations

Peers

Liangji Li
Shuhao Feng China
Ankit Jambusaria United States
Kristine D. Estrada United States
Nishani S. Mabotuwana Australia
Weijie Dong China
Yiming Zhu China
Chandan K. Nagaraju Belgium
Andrea Mattiotti Netherlands
Emma C. Watson Germany
Shuhao Feng China
Liangji Li
Citations per year, relative to Liangji Li Liangji Li (= 1×) peers Shuhao Feng

Countries citing papers authored by Liangji Li

Since Specialization
Citations

This map shows the geographic impact of Liangji Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangji Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangji Li more than expected).

Fields of papers citing papers by Liangji Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangji Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangji Li. The network helps show where Liangji Li may publish in the future.

Co-authorship network of co-authors of Liangji Li

This figure shows the co-authorship network connecting the top 25 collaborators of Liangji Li. A scholar is included among the top collaborators of Liangji Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangji Li. Liangji Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Yang, Jin‐Hao, Yuan Li, Qiuyan Chen, et al.. (2025). DDAH1 Promotes Cisplatin Chemoresistance in Patients with Locally Advanced Nasopharyngeal Carcinoma via the EGFR‐JAK2‐STAT3 Pathway. Advanced Science. 12(30). e03647–e03647.
2.
Jia, Guodong, Xiaoyun Li, Liangji Li, et al.. (2025). Endoplasmic reticulum-localized circular RNA FAM13B restrains nasopharyngeal carcinoma lymphatic metastasis through downregulating XBP1. Journal of Experimental & Clinical Cancer Research. 44(1). 223–223.
3.
4.
Lee, Jun Ho, Francisco J. Sánchez‐Rivera, Lan He, et al.. (2024). TGF-β and RAS jointly unmask primed enhancers to drive metastasis. Cell. 187(22). 6182–6199.e29. 29 indexed citations
5.
Lee, Jun Ho, Harihar Basnet, Francisco J. Sánchez‐Rivera, et al.. (2023). Abstract PR004: Mechanistic basis for TGF-β-induced fibrogenic EMTs in metastasis. Cancer Research. 83(2_Supplement_2). PR004–PR004.
6.
Li, Yuan, Shibing Li, Qiuyan Chen, et al.. (2022). EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal carcinoma. Cell Death and Differentiation. 29(8). 1513–1527. 104 indexed citations
7.
Li, Liangji, Michelle Rozo, Sibiao Yue, et al.. (2019). Muscle stem cell renewal suppressed by GAS1 can be reversed by GDNF in mice. Nature Metabolism. 1(10). 985–995. 23 indexed citations
8.
Rozo, Michelle, Liangji Li, & Chen‐Ming Fan. (2016). Targeting β1-integrin signaling enhances regeneration in aged and dystrophic muscle in mice. Nature Medicine. 22(8). 889–896. 168 indexed citations
9.
Kann, Martin, Eunnyung Bae, Maximilian Lenz, et al.. (2015). WT1 targetsGas1to maintain nephron progenitor cells by modulating FGF signals. Development. 142(7). 1254–1266. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuhao Feng Breakdown of academic impact, for papers by Ankit Jambusaria Breakdown of academic impact, for papers by Kristine D. Estrada Breakdown of academic impact, for papers by Nishani S. Mabotuwana Breakdown of academic impact, for papers by Weijie Dong Breakdown of academic impact, for papers by Yiming Zhu Breakdown of academic impact, for papers by Chandan K. Nagaraju Breakdown of academic impact, for papers by Andrea Mattiotti Breakdown of academic impact, for papers by Emma C. Watson
Rankless by CCL
2026